Apellis Pharmaceuticals Inc (APLS) 41.03 USD (%) | Healthcare & Biotech NASDAQ

Warning: The stock Apellis Pharmaceuticals Inc has been delisted from NASDAQ market 3 weeks ago.

Apellis Pharmaceuticals Inc is a biopharmaceutical company focused on the development of innovative therapies to treat autoimmune and inflammatory diseases.

This stock is no longer available on the market.

Momentum is clearly positive and suggests a shift in market perception in favor of the stock. The recent trend is much more constructive than the longer-term history, indicating a re-rating phase supported by more favorable expectations around execution and pipeline visibility. For a retail investor, the story remains attractive from a momentum standpoint, but it should be approached as a speculative growth stock

Apellis Pharmaceuticals Inc

Trend Analysis of Apellis Pharmaceuticals Inc

Want to see the full analysis?